Skip to content

Clinical trials

Completed Lung Diseases, Obstructive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Obstructive Status: Completed Clear all

141 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20034
20041
200510
20061
20072
20083
20095
20105
20114
20127
20132
201410
20158
201611
20176
20186
20193
20204
20213
20225
20237
20243
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed141

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)25
AstraZeneca19
University of Zurich7
University of Michigan5
Assistance Publique - Hôpitaux de Paris3
Novartis Pharmaceuticals3
Radboud University Medical Center3
Royal Brompton & Harefield NHS Foundation Trust3
Catholic University of the Sacred Heart2
Columbia University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Obstructive141
Pulmonary Disease, Chronic Obstructive81
Lung Diseases52
Asthma42
Respiratory Tract Diseases35
Bronchial Diseases25
Emphysema14
Bronchitis, Chronic8
Immune System Diseases7
Cardiovascular Diseases6

Trials

Showing 26 to 50 of 141. Each trial links to its page on Pharma Observatory.

41 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.